TY - JOUR AU - Lim, S. S. AU - Vos, T. AU - Flaxman, A. D. AU - Danaei, G. AU - Shibuya, K. AU - Adair-Rohani, H. PY - 2012 DA - 2012// TI - A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 JO - Lancet VL - 380 UR - https://doi.org/10.1016/S0140-6736(12)61766-8 DO - 10.1016/S0140-6736(12)61766-8 ID - Lim2012 ER - TY - BOOK PY - 2015 DA - 2015// TI - Atlas of heart disease and stroke ID - ref2 ER - TY - JOUR AU - Miner, J. AU - Hoffhines, A. PY - 2007 DA - 2007// TI - The discovery of aspirin’s antithrombotic effects JO - Tex Heart Inst J VL - 34 ID - Miner2007 ER - TY - JOUR AU - Hayden, M. AU - Pignone, M. AU - Phillips, C. AU - Mulrow, C. PY - 2002 DA - 2002// TI - Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the US Preventive Services Task Force JO - Ann Intern Med VL - 136 UR - https://doi.org/10.7326/0003-4819-136-2-200201150-00016 DO - 10.7326/0003-4819-136-2-200201150-00016 ID - Hayden2002 ER - TY - JOUR AU - Bhatt, D. L. AU - Eagle, K. A. AU - Ohman, E. M. AU - Hirsch, A. T. AU - Goto, S. AU - Mahoney, E. M. PY - 2010 DA - 2010// TI - Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis JO - JAMA VL - 304 UR - https://doi.org/10.1001/jama.2010.1322 DO - 10.1001/jama.2010.1322 ID - Bhatt2010 ER - TY - JOUR AU - Baigent, C. AU - Blackwell, L. AU - Collins, R. AU - Emberson, J. AU - Godwin, J. PY - 2009 DA - 2009// TI - Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials JO - Lancet VL - 373 UR - https://doi.org/10.1016/S0140-6736(09)60503-1 DO - 10.1016/S0140-6736(09)60503-1 ID - Baigent2009 ER - TY - JOUR AU - Berger, J. S. AU - Roncaglioni, M. C. AU - Avanzini, F. AU - Pangrazzi, I. AU - Tognoni, G. AU - Brown, D. L. PY - 2006 DA - 2006// TI - Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials JO - JAMA VL - 295 UR - https://doi.org/10.1001/jama.295.3.306 DO - 10.1001/jama.295.3.306 ID - Berger2006 ER - TY - JOUR AU - Berger, J. S. AU - Lala, A. AU - Krantz, M. J. AU - Baker, G. S. AU - Hiatt, W. R. PY - 2011 DA - 2011// TI - Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials JO - Am Heart J VL - 162 ID - Berger2011 ER - TY - JOUR AU - Seshasai, S. R. AU - Wijesuriya, S. AU - Sivakumaran, R. AU - Nethercott, S. AU - Erqou, S. AU - Sattar, N. PY - 2012 DA - 2012// TI - Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials JO - Arch Intern Med VL - 172 UR - https://doi.org/10.1001/archinternmed.2011.628 DO - 10.1001/archinternmed.2011.628 ID - Seshasai2012 ER - TY - JOUR AU - Cooney, M. T. AU - Dudina, A. AU - Whincup, P. AU - Capewell, S. AU - Menotti, A. AU - Jousilahti, P. PY - 2009 DA - 2009// TI - Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies JO - Eur J Cardiovasc Prev Rehabil VL - 16 UR - https://doi.org/10.1097/HJR.0b013e32832b38a1 DO - 10.1097/HJR.0b013e32832b38a1 ID - Cooney2009 ER - TY - JOUR AU - Miedema, M. D. AU - Cohn, J. N. AU - Garberich, R. AU - Henry, J. AU - Graham, K. J. AU - Henry, T. D. PY - 2012 DA - 2012// TI - Under-use of cardiovascular preventive pharmacotherapy in patients presenting with ST-elevation myocardial infarction JO - Am Heart J VL - 164 UR - https://doi.org/10.1016/j.ahj.2012.05.008 DO - 10.1016/j.ahj.2012.05.008 ID - Miedema2012 ER - TY - JOUR AU - Jingi, A. M. AU - Noubiap, J. J. AU - Ewane Onana, A. AU - Nansseu, J. R. AU - Wang, B. AU - Kingue, S. PY - 2014 DA - 2014// TI - Access to diagnostic tests and essential medicines for cardiovascular diseases and diabetes care: cost, availability and affordability in the West Region of Cameroon JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0111812 DO - 10.1371/journal.pone.0111812 ID - Jingi2014 ER - TY - JOUR AU - Mendis, S. AU - Fukino, K. AU - Cameron, A. AU - Laing, R. AU - Filipe, A. AU - Khatib, O. PY - 2007 DA - 2007// TI - The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries JO - Bull World Health Organ VL - 85 UR - https://doi.org/10.2471/BLT.06.033647 DO - 10.2471/BLT.06.033647 ID - Mendis2007 ER - TY - JOUR AU - Mendis, S. AU - Al Bashir, I. AU - Dissanayake, L. AU - Varghese, C. AU - Fadhil, I. AU - Marhe, E. PY - 2012 DA - 2012// TI - Gaps in capacity in primary care in low-resource settings for implementation of essential noncommunicable disease interventions JO - Int J Hypertens VL - 2012 ID - Mendis2012 ER - TY - JOUR AU - Davies, M. J. AU - Thomas, A. PY - 1984 DA - 1984// TI - Thrombosis and acute coronary artery lesions in sudden cardiac death JO - N Engl J Med VL - 310 UR - https://doi.org/10.1056/NEJM198405033101801 DO - 10.1056/NEJM198405033101801 ID - Davies1984 ER - TY - JOUR AU - Davies, M. J. AU - Thomas, A. C. PY - 1985 DA - 1985// TI - Plaque fissuring—the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina JO - Br Heart J VL - 53 UR - https://doi.org/10.1136/hrt.53.4.363 DO - 10.1136/hrt.53.4.363 ID - Davies1985 ER - TY - JOUR AU - Santos-Gallego, C. G. AU - Picatoste, B. AU - Badimón, J. J. PY - 2014 DA - 2014// TI - Pathophysiology of acute coronary syndrome JO - Curr Atheroscler Rep VL - 16 UR - https://doi.org/10.1007/s11883-014-0401-9 DO - 10.1007/s11883-014-0401-9 ID - Santos-Gallego2014 ER - TY - JOUR AU - Patrono, C. AU - Ciabattoni, G. AU - Patrignani, P. AU - Pugliese, F. AU - Filabozzi, P. AU - Catella, F. PY - 1985 DA - 1985// TI - Clinical pharmacology of platelet cyclooxygenase inhibition JO - Circulation VL - 72 UR - https://doi.org/10.1161/01.CIR.72.6.1177 DO - 10.1161/01.CIR.72.6.1177 ID - Patrono1985 ER - TY - JOUR AU - Redondo, S. AU - Santos-Gallego, C. G. AU - Ganado, P. AU - García, M. AU - Rico, L. AU - Rio, M. PY - 2003 DA - 2003// TI - Acetylsalicylic acid inhibits cell proliferation by involving transforming growth factor-beta JO - Circulation VL - 107 UR - https://doi.org/10.1161/01.CIR.0000045664.75269.A5 DO - 10.1161/01.CIR.0000045664.75269.A5 ID - Redondo2003 ER - TY - JOUR AU - Redondo, S. AU - Santos-Gallego, C. G. AU - Tejerina, T. PY - 2007 DA - 2007// TI - TGF-beta1: a novel target for cardiovascular pharmacology JO - Cytokine Growth Factor Rev VL - 18 UR - https://doi.org/10.1016/j.cytogfr.2007.04.005 DO - 10.1016/j.cytogfr.2007.04.005 ID - Redondo2007 ER - TY - JOUR AU - He, J. AU - Whelton, P. K. AU - Vu, B. AU - Klag, M. J. PY - 1998 DA - 1998// TI - Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials JO - JAMA VL - 280 UR - https://doi.org/10.1001/jama.280.22.1930 DO - 10.1001/jama.280.22.1930 ID - He1998 ER - TY - JOUR PY - 2002 DA - 2002// TI - Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardialinfarction, and stroke in high risk patients JO - BMJ VL - 324 UR - https://doi.org/10.1136/bmj.324.7329.71 DO - 10.1136/bmj.324.7329.71 ID - ref22 ER - TY - JOUR AU - Berardis, G. AU - Lucisano, G. AU - D’Ettorre, A. AU - Pellegrini, F. AU - Lepore, V. AU - Tognoni, G. PY - 2012 DA - 2012// TI - Association of aspirin use with major bleeding in patients with and without diabetes JO - JAMA VL - 307 UR - https://doi.org/10.1001/jama.2012.5034 DO - 10.1001/jama.2012.5034 ID - Berardis2012 ER - TY - JOUR AU - Ikeda, Y. AU - Shimada, K. AU - Teramoto, T. AU - Uchiyama, S. AU - Yamazaki, T. AU - Oikawa, S. PY - 2014 DA - 2014// TI - Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial JO - JAMA VL - 312 UR - https://doi.org/10.1001/jama.2014.15690 DO - 10.1001/jama.2014.15690 ID - Ikeda2014 ER - TY - STD TI - Sasso FC, Marfella R, Pagano A, Porta G, Signoriello G, Lascar N, et al. Lack of effect of aspirin in primary CV prevention in type 2 diabetic patients with nephropathy: results from 8 years follow-up of NID-2 study. Acta Diabetol. 2014; [Epub ahead of print]. ID - ref25 ER - TY - JOUR AU - Lin, K. J. AU - Caterina, R. AU - García Rodríguez, L. A. PY - 2014 DA - 2014// TI - Low-dose aspirin and upper gastrointestinal bleeding in primary versus secondary cardiovascular prevention: a population-based, nested case–control study JO - Circ Cardiovasc Qual Outcomes VL - 7 UR - https://doi.org/10.1161/CIRCOUTCOMES.113.000494 DO - 10.1161/CIRCOUTCOMES.113.000494 ID - Lin2014 ER - TY - JOUR AU - Miedema, M. D. AU - Duprez, D. A. AU - Misialek, J. R. AU - Blaha, M. J. AU - Nasir, K. AU - Silverman, M. G. PY - 2014 DA - 2014// TI - Use of coronary artery calcium testing to guide aspirin utilization for primary prevention: estimates from the multi-ethnic study of atherosclerosis JO - Circ Cardiovasc Qual Outcomes VL - 7 UR - https://doi.org/10.1161/CIRCOUTCOMES.113.000690 DO - 10.1161/CIRCOUTCOMES.113.000690 ID - Miedema2014 ER - TY - JOUR AU - Fowkes, F. G. AU - Price, J. F. AU - Stewart, M. C. AU - Butcher, I. AU - Leng, G. C. AU - Pell, A. C. PY - 2010 DA - 2010// TI - Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial JO - JAMA VL - 303 UR - https://doi.org/10.1001/jama.2010.221 DO - 10.1001/jama.2010.221 ID - Fowkes2010 ER - TY - JOUR AU - Ogawa, H. AU - Nakayama, M. AU - Morimoto, T. AU - Uemura, S. AU - Kanauchi, M. AU - Doi, N. PY - 2008 DA - 2008// TI - Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial JO - JAMA VL - 300 UR - https://doi.org/10.1001/jama.2008.623 DO - 10.1001/jama.2008.623 ID - Ogawa2008 ER - TY - JOUR AU - Sutcliffe, P. AU - Connock, M. AU - Gurung, T. AU - Freeman, K. AU - Johnson, S. AU - Ngianga-Bakwin, K. PY - 2013 DA - 2013// TI - Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0081970 DO - 10.1371/journal.pone.0081970 ID - Sutcliffe2013 ER - TY - JOUR AU - Sutcliffe, P. AU - Connock, M. AU - Gurung, T. AU - Freeman, K. AU - Johnson, S. AU - Kandala, N. B. PY - 2013 DA - 2013// TI - Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews JO - Health Technol Assess VL - 17 ID - Sutcliffe2013 ER - TY - JOUR AU - Vandvik, P. O. AU - Lincoff, A. M. AU - Gore, J. M. AU - Gutterman, D. D. AU - Sonnenberg, F. A. AU - Alonso-Coello, P. PY - 2012 DA - 2012// TI - Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines JO - Chest VL - 141 UR - https://doi.org/10.1378/chest.11-2306 DO - 10.1378/chest.11-2306 ID - Vandvik2012 ER - TY - JOUR AU - Patrono, C. AU - Garcia Rodriguez, L. A. AU - Landolfi, R. AU - Baigent, C. PY - 2005 DA - 2005// TI - Low-dose aspirin for the prevention of atherothrombosis JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMra052717 DO - 10.1056/NEJMra052717 ID - Patrono2005 ER - TY - JOUR AU - Park, K. AU - Bavry, A. A. PY - 2013 DA - 2013// TI - Aspirin: its risks, benefits, and optimal use in preventing cardiovascular events JO - Cleve Clin J Med VL - 80 UR - https://doi.org/10.3949/ccjm.80a.12146 DO - 10.3949/ccjm.80a.12146 ID - Park2013 ER - TY - JOUR AU - Lip, G. Y. PY - 2013 DA - 2013// TI - Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why? JO - Eur Heart J VL - 34 UR - https://doi.org/10.1093/eurheartj/ehs435 DO - 10.1093/eurheartj/ehs435 ID - Lip2013 ER - TY - JOUR AU - Apostolakis, S. AU - Lane, D. A. AU - Guo, Y. AU - Buller, H. AU - Lip, G. Y. PY - 2012 DA - 2012// TI - Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study JO - J Am Coll Cardiol VL - 60 UR - https://doi.org/10.1016/j.jacc.2012.06.019 DO - 10.1016/j.jacc.2012.06.019 ID - Apostolakis2012 ER - TY - JOUR AU - Pisters, R. AU - Lane, D. A. AU - Nieuwlaat, R. AU - Vos, C. B. AU - Crijns, H. J. AU - Lip, G. Y. PY - 2010 DA - 2010// TI - A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey JO - Chest VL - 138 UR - https://doi.org/10.1378/chest.10-0134 DO - 10.1378/chest.10-0134 ID - Pisters2010 ER - TY - JOUR AU - Lane, D. A. AU - Lip, G. Y. PY - 2012 DA - 2012// TI - Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation JO - Circulation VL - 126 UR - https://doi.org/10.1161/CIRCULATIONAHA.111.060061 DO - 10.1161/CIRCULATIONAHA.111.060061 ID - Lane2012 ER - TY - JOUR AU - Campbell, C. L. AU - Smyth, S. AU - Montalescot, G. AU - Steinhubl, S. R. PY - 2007 DA - 2007// TI - Aspirin dose for the prevention of cardiovascular disease: a systematic review JO - JAMA VL - 297 UR - https://doi.org/10.1001/jama.297.18.2018 DO - 10.1001/jama.297.18.2018 ID - Campbell2007 ER - TY - JOUR AU - Mehta, S. R. AU - Bassand, J. P. AU - Chrolavicius, S. AU - Diaz, R. AU - Eikelboom, J. W. PY - 2010 DA - 2010// TI - Dose comparisons of clopidogrel and aspirin in acute coronary syndromes JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa0909475 DO - 10.1056/NEJMoa0909475 ID - Mehta2010 ER - TY - JOUR AU - Simpson, S. H. AU - Gamble, J. M. AU - Mereu, L. AU - Chambers, T. PY - 2011 DA - 2011// TI - Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysis JO - J Gen Intern Med VL - 26 UR - https://doi.org/10.1007/s11606-011-1757-y DO - 10.1007/s11606-011-1757-y ID - Simpson2011 ER - TY - JOUR AU - Weil, J. AU - Colin-Jones, D. AU - Langman, M. AU - Lawson, D. AU - Logan, R. AU - Murphy, M. PY - 1995 DA - 1995// TI - Prophylactic aspirin and risk of peptic ulcer bleeding JO - BMJ VL - 310 UR - https://doi.org/10.1136/bmj.310.6983.827 DO - 10.1136/bmj.310.6983.827 ID - Weil1995 ER - TY - JOUR AU - Russo, P. AU - Brutti, C. PY - 2007 DA - 2007// TI - Proton pump inhibitors and hospital discharge rates for gastrointestinal events in Italy: a national ecological study JO - Clin Ther VL - 29 UR - https://doi.org/10.1016/j.clinthera.2007.04.008 DO - 10.1016/j.clinthera.2007.04.008 ID - Russo2007 ER - TY - JOUR AU - Earnshaw, S. R. AU - Scheiman, J. AU - Fendrick, A. M. AU - McDade, C. AU - Pignone, M. PY - 2011 DA - 2011// TI - Cost-utility of aspirin and proton pump inhibitors for primary prevention JO - Arch Intern Med VL - 17 UR - https://doi.org/10.1001/archinternmed.2010.525 DO - 10.1001/archinternmed.2010.525 ID - Earnshaw2011 ER - TY - JOUR AU - Charlot, M. AU - Grove, E. L. AU - Hansen, P. R. AU - Olesen, J. B. AU - Ahlehoff, O. AU - Selmer, C. PY - 2011 DA - 2011// TI - Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study JO - BMJ VL - 342 UR - https://doi.org/10.1136/bmj.d2690 DO - 10.1136/bmj.d2690 ID - Charlot2011 ER - TY - JOUR AU - Lai, K. C. AU - Chu, K. M. AU - Hui, W. M. AU - Wong, B. C. AU - Hung, W. K. AU - Loo, C. K. PY - 2006 DA - 2006// TI - Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications JO - Clin Gastroenterol Hepatol VL - 4 UR - https://doi.org/10.1016/j.cgh.2006.04.019 DO - 10.1016/j.cgh.2006.04.019 ID - Lai2006 ER - TY - JOUR AU - Chan, F. K. AU - CHing, J. Y. AU - Hung, L. C. AU - Wong, V. W. AU - Leung, V. K. AU - Kung, N. N. PY - 2005 DA - 2005// TI - Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa042087 DO - 10.1056/NEJMoa042087 ID - Chan2005 ER - TY - JOUR AU - Cleland, J. G. PY - 2013 DA - 2013// TI - Is aspirin useful in primary prevention? JO - Eur Heart J VL - 34 UR - https://doi.org/10.1093/eurheartj/eht287 DO - 10.1093/eurheartj/eht287 ID - Cleland2013 ER - TY - JOUR AU - Ranke, C. AU - Hecker, H. AU - Creutzig, A. AU - Alexander, K. PY - 1993 DA - 1993// TI - Dose-dependent effect of aspirin on carotid atherosclerosis JO - Circulation VL - 87 UR - https://doi.org/10.1161/01.CIR.87.6.1873 DO - 10.1161/01.CIR.87.6.1873 ID - Ranke1993 ER - TY - JOUR AU - Goff, D. C. AU - Lloyd-Jones, D. M. AU - Bennett, G. AU - Coady, S. AU - D’Agostino, R. B. AU - Gibbons, R. PY - 2013 DA - 2013// TI - ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines JO - J Am Coll Cardiol VL - 2014 ID - Goff2013 ER - TY - JOUR AU - Perk, J. AU - Backer, G. AU - Gohlke, H. AU - Graham, I. AU - Reiner, Z. AU - Verschuren, M. PY - 2012 DA - 2012// TI - The fifth joint task force of the european society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) JO - Eur Heart J VL - 2012 ID - Perk2012 ER - TY - JOUR AU - Amarenco, P. AU - Bogousslavsky, J. AU - Callahan, A. AU - Goldstein, L. B. AU - Hennerici, M. AU - Rudolph, A. E. PY - 2006 DA - 2006// TI - High-dose atorvastatin after stroke or transient ischemic attack JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa061894 DO - 10.1056/NEJMoa061894 ID - Amarenco2006 ER - TY - JOUR AU - Nasir, K. AU - Rubin, J. AU - Blaha, M. J. AU - Shaw, L. J. AU - Blankstein, R. AU - Rivera, J. J. PY - 2012 DA - 2012// TI - Interplay of coronary artery calcification and traditional risk factors for the prediction of all-cause mortality in asymptomatic individuals JO - Circ Cardiovasc Imaging VL - 5 UR - https://doi.org/10.1161/CIRCIMAGING.111.964528 DO - 10.1161/CIRCIMAGING.111.964528 ID - Nasir2012 ER - TY - JOUR AU - Newman, A. B. AU - Siscovick, D. S. AU - Manolio, T. A. AU - Polak, J. AU - Fried, L. P. AU - Borhani, N. O. PY - 1993 DA - 1993// TI - Ankle-arm index as a marker of atherosclerosis in the cardiovascular health study. Cardiovascular Heart Study (CHS) Collaborative Research Group JO - Circulation VL - 88 UR - https://doi.org/10.1161/01.CIR.88.3.837 DO - 10.1161/01.CIR.88.3.837 ID - Newman1993 ER - TY - JOUR AU - Collaboration, A. B. I. AU - Fowkes, F. G. AU - Murray, G. D. AU - Butcher, I. AU - Heald, C. L. AU - Lee, R. J. PY - 2008 DA - 2008// TI - Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis JO - JAMA VL - 300 UR - https://doi.org/10.1001/jama.300.2.197 DO - 10.1001/jama.300.2.197 ID - Collaboration2008 ER - TY - JOUR AU - Yusuf, S. AU - Hawken, S. AU - Ounpuu, S. AU - Dans, T. AU - Avezum, A. AU - Lanas, F. PY - 2004 DA - 2004// TI - Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study JO - Lancet VL - 364 UR - https://doi.org/10.1016/S0140-6736(04)17018-9 DO - 10.1016/S0140-6736(04)17018-9 ID - Yusuf2004 ER - TY - JOUR AU - McGorrian, C. AU - Yusuf, S. AU - Islam, S. AU - Jung, H. AU - Rangarajan, S. AU - Avezum, A. PY - 2011 DA - 2011// TI - Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score JO - Eur Heart J VL - 32 UR - https://doi.org/10.1093/eurheartj/ehq448 DO - 10.1093/eurheartj/ehq448 ID - McGorrian2011 ER - TY - STD TI - Noubiap JJ, Nansseu JR. Are the current recommendations for the use of aspirin in primary prevention of cardiovascular disease applicable in low-income countries? Vasc Health Risk Manag. 2015; In press. ID - ref58 ER - TY - JOUR AU - Bartolucci, A. A. AU - Tendera, M. AU - Howard, G. PY - 2011 DA - 2011// TI - Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin JO - Am J Cardiol VL - 107 UR - https://doi.org/10.1016/j.amjcard.2011.02.325 DO - 10.1016/j.amjcard.2011.02.325 ID - Bartolucci2011 ER - TY - JOUR AU - Raju, N. AU - Sobieraj-Teague, M. AU - Hirsh, J. AU - O’Donnell, M. AU - Eikelboom, J. PY - 2011 DA - 2011// TI - Effect of aspirin on mortality in the primary prevention of cardiovascular disease JO - Am J Med VL - 124 UR - https://doi.org/10.1016/j.amjmed.2011.01.018 DO - 10.1016/j.amjmed.2011.01.018 ID - Raju2011 ER - TY - BOOK AU - Jones, W. S. AU - Schmit, K. M. AU - Vemulapalli, S. AU - Subherwal, S. AU - Patel, M. R. AU - Hasselblad, V. PY - 2013 DA - 2013// TI - Treatment strategies for patients with peripheral artery disease [Internet] PB - Agency for Healthcare Research and Quality (US) CY - Rockville, MD ID - Jones2013 ER - TY - JOUR AU - Brighton, T. A. AU - Eikelboom, J. W. AU - Mann, K. AU - Mister, R. AU - Gallus, A. AU - Ockelford, P. PY - 2012 DA - 2012// TI - Low-dose aspirin for preventing recurrent venous thromboembolism JO - N Engl J Med VL - 367 UR - https://doi.org/10.1056/NEJMoa1210384 DO - 10.1056/NEJMoa1210384 ID - Brighton2012 ER - TY - JOUR AU - Haffner, S. M. AU - Lehto, S. AU - Rönnemaa, T. AU - Pyörälä, K. AU - Laakso, M. PY - 1998 DA - 1998// TI - Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction JO - N Engl J Med VL - 339 UR - https://doi.org/10.1056/NEJM199807233390404 DO - 10.1056/NEJM199807233390404 ID - Haffner1998 ER - TY - JOUR AU - Feigin, V. L. AU - Rinkel, G. J. AU - Lawes, C. M. AU - Algra, A. AU - Bennett, D. A. AU - Gijn, J. PY - 2005 DA - 2005// TI - Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies JO - Stroke VL - 36 UR - https://doi.org/10.1161/01.STR.0000190838.02954.e8 DO - 10.1161/01.STR.0000190838.02954.e8 ID - Feigin2005 ER - TY - STD TI - No authors listed. Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early treatment diabetic retinopathy study report 14. ETDRS Investigators. JAMA. 1992;268:1292–1300. ID - ref65 ER - TY - STD TI - No authors listed. Final report on the aspirin component of the ongoing physicians’ health study. Steering Committee of the Physicians’ Health Study Research Group. N Engl J Med. 1989;321:129–135. ID - ref66 ER - TY - JOUR AU - Belch, J. AU - MacCuish, A. AU - Campbell, I. AU - Cobbe, S. AU - Taylor, R. AU - Prescott, R. PY - 2008 DA - 2008// TI - The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease JO - BMJ VL - 337 UR - https://doi.org/10.1136/bmj.a1840 DO - 10.1136/bmj.a1840 ID - Belch2008 ER - TY - JOUR AU - Gaetano, G. PY - 2001 DA - 2001// TI - Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative group of the primary prevention project JO - Lancet VL - 357 UR - https://doi.org/10.1016/S0140-6736(00)04717-6 DO - 10.1016/S0140-6736(00)04717-6 ID - Gaetano2001 ER - TY - JOUR AU - Butalia, S. AU - Leung, A. A. AU - Ghali, W. A. AU - Rabi, D. M. PY - 2011 DA - 2011// TI - Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis JO - Cardiovasc Diabetol VL - 10 UR - https://doi.org/10.1186/1475-2840-10-25 DO - 10.1186/1475-2840-10-25 ID - Butalia2011 ER - TY - JOUR AU - Halvorsen, S. AU - Andreotti, F. AU - Berg, J. M. AU - Cattaneo, M. AU - Coccheri, S. AU - Marchioli, R. PY - 2014 DA - 2014// TI - Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis JO - J Am Coll Cardiol VL - 64 UR - https://doi.org/10.1016/j.jacc.2014.03.049 DO - 10.1016/j.jacc.2014.03.049 ID - Halvorsen2014 ER - TY - JOUR AU - Barnett, H. AU - Burrill, P. AU - Iheanacho, I. PY - 2010 DA - 2010// TI - Don’t use aspirin for primary prevention of cardiovascular disease JO - BMJ VL - 340 UR - https://doi.org/10.1136/bmj.c1805 DO - 10.1136/bmj.c1805 ID - Barnett2010 ER - TY - JOUR AU - Pearson, T. A. AU - Blair, S. N. AU - Daniels, S. R. AU - Eckel, R. H. AU - Fair, J. M. AU - Fortmann, S. P. PY - 2002 DA - 2002// TI - AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 Update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee JO - Circulation VL - 2002 UR - https://doi.org/10.1161/01.CIR.0000020190.45892.75 DO - 10.1161/01.CIR.0000020190.45892.75 ID - Pearson2002 ER - TY - JOUR AU - Hennekens, C. H. AU - DeMets, D. L. PY - 2014 DA - 2014// TI - Prevention: aspirin in primary prevention needs individual judgements JO - Nat Rev Cardiol VL - 11 UR - https://doi.org/10.1038/nrcardio.2014.88 DO - 10.1038/nrcardio.2014.88 ID - Hennekens2014 ER - TY - JOUR AU - Fiscella, K. AU - Winters, P. C. AU - Mendoza, M. AU - Noronha, G. J. AU - Swanger, C. M. AU - Bisognano, J. D. PY - 2015 DA - 2015// TI - Do clinicians recommend aspirin to patients for primary prevention of cardiovascular disease? JO - J Gen Intern Med VL - 30 UR - https://doi.org/10.1007/s11606-014-2985-8 DO - 10.1007/s11606-014-2985-8 ID - Fiscella2015 ER - TY - JOUR AU - Persell, S. D. AU - Lloyd-Jones, D. M. AU - Friesema, E. M. AU - Cooper, A. J. AU - Baker, D. W. PY - 2013 DA - 2013// TI - Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial JO - J Gen Intern Med VL - 28 UR - https://doi.org/10.1007/s11606-012-2268-1 DO - 10.1007/s11606-012-2268-1 ID - Persell2013 ER - TY - JOUR AU - Ghorob, A. AU - Bodenheimer, T. PY - 2012 DA - 2012// TI - Sharing the care to improve access to primary care JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMp1202775 DO - 10.1056/NEJMp1202775 ID - Ghorob2012 ER - TY - JOUR AU - Sheridan, S. L. AU - Viera, A. J. AU - Krantz, M. J. AU - Ice, C. L. AU - Steinman, L. E. AU - Peters, K. E. PY - 2010 DA - 2010// TI - The effect of giving global coronary risk information to adults: a systematic review JO - Arch Intern Med VL - 170 UR - https://doi.org/10.1001/archinternmed.2009.516 DO - 10.1001/archinternmed.2009.516 ID - Sheridan2010 ER - TY - JOUR AU - Pignone, M. AU - Alberts, M. J. AU - Colwell, J. A. AU - Cushman, M. AU - Inzucchi, S. E. AU - Mukherjee, D. PY - 2010 DA - 2010// TI - Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation JO - Circulation VL - 121 UR - https://doi.org/10.1161/CIR.0b013e3181e3b133 DO - 10.1161/CIR.0b013e3181e3b133 ID - Pignone2010 ER - TY - JOUR AU - Meschia, J. F. AU - Bushnell, C. AU - Boden-Albala, B. AU - Braun, L. T. AU - Bravata, D. M. AU - Chaturvedi, S. PY - 2014 DA - 2014// TI - Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association JO - Stroke VL - 45 UR - https://doi.org/10.1161/STR.0000000000000046 DO - 10.1161/STR.0000000000000046 ID - Meschia2014 ER - TY - JOUR AU - Alonso-Coello, P. AU - Bellmunt, S. AU - McGorrian, C. AU - Anand, S. S. AU - Guzman, R. AU - Criqui, M. H. PY - 2012 DA - 2012// TI - Antithrombotic therapy in peripheral artery disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines JO - Chest VL - 141 ID - Alonso-Coello2012 ER - TY - JOUR AU - Bell, A. D. AU - Roussin, A. AU - Cartier, R. AU - Chan, W. S. AU - Douketis, J. D. AU - Gupta, A. PY - 2011 DA - 2011// TI - The use of antiplatelet therapy in the outpatient setting: Canadian cardiovascular society guidelines executive summary JO - Can J Cardiol VL - 27 UR - https://doi.org/10.1016/j.cjca.2010.12.033 DO - 10.1016/j.cjca.2010.12.033 ID - Bell2011 ER - TY - JOUR AU - Perk, J. AU - Backer, G. AU - Gohlke, H. AU - Graham, I. AU - Reiner, Z. AU - Verschuren, M. PY - 2012 DA - 2012// TI - European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the european society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) JO - Eur Heart J VL - 33 UR - https://doi.org/10.1093/eurheartj/ehs092 DO - 10.1093/eurheartj/ehs092 ID - Perk2012 ER -